Tridom

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tridom

What is Tridom? Classification and Identity

Property Description
Active ingredient Domperidone
Form Oral formulation (Tablet, Suspension)
Pharmacological class Antiemetic Agent, Prokinetic Agent
Common use Relief from nausea and vomiting
Origin Synthetic organic (Benzimidazole Derivative)

Tridom is a medicinal product whose active ingredient is Domperidone, functioning as both an Antiemetic Agent and a Prokinetic Agent. Its primary role is addressing gastrointestinal discomfort and sickness. This single-ingredient product is a synthetic organic compound chemically classified as a Benzimidazole Derivative.

The medicine's identity is defined by its two main classifications, clinically recognized for both suppressing sickness and promoting coordinated digestive movement. Domperidone is an oral formulation intended for oral administration, and Tridom is available in several Pharmaceutical Preparations, including a standard Tablet, a liquid Suspension, and a specialized Dispersible Tablet (Tablet DT), providing versatile options for adolescents and adults.

Domperidone: Composition and General Purpose

The core function is delivered by Domperidone, which acts through the Blockage of dopamine receptors located outside the central nervous system, specifically in the Chemoreceptor Trigger Zone (CTZ). This mechanism helps localize the therapeutic effects to the digestive system.

The general purpose of Tridom is to provide relief from feelings of nausea and vomiting often associated with slow digestion. Domperidone improves the flow of material from the stomach to the small intestine. This prokinetic action means the medicine helps ease discomfort by gently stimulating and coordinating the body’s natural digestive movements. By enhancing the muscular contractions (peristalsis) in the stomach, the medicine aids in resolving conditions like delayed gastric emptying (Gastroparesis), a typical use scenario that integrates both its anti-sickness and motility-enhancing properties.

Targeted Action and Unique Profile

Tridom is distinguished by its combined antiemetic and prokinetic actions. The design of Domperidone is notable because it is engineered to have minimal penetration through the blood-brain barrier. This characteristic ensures that the drug's effects are primarily focused on the gastrointestinal system and the CTZ, differentiating its action profile from some antiemetic compounds that more broadly affect the central nervous system.

Regulatory References

  1. Domperidone - Drugs and Lactation Database (LactMed)

What side effects are possible with Tridom?

Possible Side Effects and Safety Information

The safety profile of Tridom (Domperidone) is officially documented by government regulatory bodies, detailing potential side effects and specific safety limitations. Adverse reactions are classified by frequency and the body system affected, demonstrating expertise in interpreting official safety classifications.


Official Adverse Reaction Classifications

Side effects are categorized based on their incidence as documented in prescribing information:

Category Examples (System-Organ Classes)
Common Nervous System (Headache), Gastrointestinal (Dry mouth)
Uncommon Gastrointestinal (Abdominal cramps, Diarrhea, Regurgitation), Skin (Rash, Pruritus)
Endocrine/Reproductive Galactorrhea, Gynecomastia, Menstrual irregularities

Serious Safety Considerations

Serious adverse reactions, though classified as Very Rare or Not Known, are explicitly highlighted in official documents. These include serious ventricular arrhythmias (such as Torsade de Pointes) and Sudden Cardiac Death. Regulatory authorities have emphasized that the risk of these cardiac effects is documented as being greatest at high doses or when the medicine is used for a longer period.

Safety notes also exist for Population-Specific Safety. For example, an increased risk of serious heart rhythm abnormalities is noted for older adults. Furthermore, the medicine is contraindicated in patients with moderate or severe hepatic impairment and pre-existing cardiac conditions that affect conduction, such as QTc prolongation or congestive heart failure.

Overdose and Emergency Response

Overdose and when to seek help

The regulatory documents for Tridom (Domperidone) strictly define the overdose profile through specific documented clinical manifestations and mandated emergency actions.

Category Official Regulatory Statements
Documented Manifestations Overdose has been associated with central nervous system signs including somnolence, disorientation, extrapyramidal reactions (involuntary movements), and convulsions (seizures).
Severe Outcome A severe cardiac risk is documented as the Prolongation of the QT interval, requiring specific vigilance.
Population Notes Infants and children are explicitly noted to have a higher potential for CNS effects following an overdose.

Emergency Actions and Management

Immediate action is required upon any suspected overdose. The official documents mandate that all users seek immediate medical attention and contact emergency services due to the potential for severe effects. The regulatory management approach is defined as symptomatic and supportive treatment, as no specific antidote is known. Procedures such as gastric lavage and administration of activated charcoal may be considered. Continuous ECG monitoring and close medical supervision are required to observe for the cardiac and neurological risks documented in the overdose context.

Regulatory Context

The official overdose statements confirm that this profile is based on regulatory prescribing information, emphasizing the serious nature of the cardiac and neurological risks at supra-therapeutic levels. The overall overdose structure requires immediate clinical assessment.

Therapeutic Uses of Tridom

What Tridom Treats: Main Uses and Benefits

Tridom, which contains the active ingredient Domperidone, is applied across domains where additional symptomatic support is needed. It is commonly used to help with symptoms related to physical discomfort, specifically nausea and vomiting. This medication is relevant for easing symptoms that interfere with daily functioning and is useful in scenarios where symptoms escalate temporarily.

It supports patients during episodes of heightened discomfort by easing the overall symptom burden of feeling sick. The use of the drug is primarily focused on addressing acute symptoms related to physical discomfort, such as nausea and vomiting. It is generally considered relevant for easing symptoms that interfere with routine activities, applied in scenarios where additional management of discomfort is required.

Applied in clinical settings that involve acute or unstable symptom patterns, it is relevant when supportive symptom management is appropriate and short-term symptomatic assistance is needed. This medication may assist with maintaining functional stability during episodes of heightened symptoms.

“It helps improve day-to-day comfort during symptomatic periods.”


Quick Fact: Used for managing Symptoms linked to physical discomfort

Regulatory References

  1. MHRA guidance on domperidone

Eligibility and Restrictions for Use

Tridom (Domperidone) is a medication used to help treat nausea, vomiting, and certain indigestion symptoms. Its use is determined by a doctor based on a patient's specific health profile.

Who Can Use Tridom (General Guidelines)

Tridom is typically prescribed for patients experiencing chronic nausea, vomiting, or other gastrointestinal motility disorders. The doctor will determine the appropriate dosage and duration of treatment, often keeping the dose and treatment period as low as possible to minimize potential risks.

Who Should Avoid Using Tridom (Contraindications)

This medication is not suitable for everyone. Do not take Tridom if you have any of the following conditions, as it may increase the risk of serious side effects:

  • Allergy: Known hypersensitivity to domperidone or any other components of the medicine.
  • Gastrointestinal Issues: Conditions where stimulating stomach movement would be harmful, such as gastrointestinal hemorrhage, mechanical obstruction, or perforation.
  • Heart Conditions: Moderate to severe heart failure, or existing prolongation of the heart's QT interval, which can increase the risk of serious heart rhythm disorders.
  • Liver Disease: Moderate or severe impairment of liver function.
  • Electrolyte Imbalances: Certain uncorrected low levels of potassium or magnesium in the blood.
  • Tumors: A pituitary gland tumor known as a prolactinoma.

Special Populations and Considerations

Population Recommendation
Children Not recommended for children under 12 years of age or adolescents weighing less than 35 kg, except in specific cases of nausea/vomiting and under specialist supervision.
Pregnant/Breastfeeding Generally avoided. It should only be used if the potential benefit justifies the potential risk, as advised by a physician.
Elderly Should be used with caution and at the lowest effective dose due to an increased risk of heart-related side effects.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Tridom (Domperidone) is primarily structured around two major regulatory constraints. Co-administration is contraindicated with potent inhibitors of the CYP3A4 metabolic enzyme, as these substances significantly increase the plasma concentration of domperidone by inhibiting its main metabolic pathway. Specific examples of these potent inhibitors include systemic azole antifungals (like Ketoconazole) and certain macrolide antibiotics (like Erythromycin).

Co-administration is also contraindicated with other QTc-prolonging medicinal products due to the documented risk of pharmacodynamic reinforcement, which increases the overall risk of serious ventricular arrhythmias. This restriction applies to various medicines regardless of their primary use. Additionally, grapefruit juice co-administration is restricted due to its potent CYP3A4 inhibitory effects.

Interaction-related Administration Notes

Interaction Type Requirement Effect on Domperidone
Gastric Acidity Modifiers Should not be taken simultaneously Lowers oral bioavailability (e.g., antacids)
Food Absorption is delayed if taken after meals Delayed absorption
Population Status Consideration for reduced dosing frequency Prolonged elimination half-life (in severe renal impairment)

Regulatory documents also note a higher risk when concurrently taking interacting medicines in patients older than 60 years.

Mechanism of Action

The mechanism of Domperidone (Tridom) is defined by its targeted and selective antagonism of Dopamine D₂ receptors primarily outside the central nervous system. This peripheral action translates into two distinct physiological outcomes by engaging the emetic and gastrointestinal motility pathways.

Peripheral Antagonism in the Emetic Cascade

This domain covers the action of Domperidone on D₂ receptors located in the Chemoreceptor Trigger Zone (CTZ), which lies outside the brain’s protective barrier. By blocking these receptors, the drug reduces the transmission of signaling sequences initiated by emetic stimuli that would otherwise be transmitted to the medullary vomiting center. This mechanism alters the physiological threshold governing the emetic reflex activation.

Modulation of Upper Gastrointestinal Motility

This pathway describes the drug’s action within the Enteric Nervous System of the stomach and duodenum. D₂ receptor blockade on enteric neurons relieves the natural inhibitory tone exerted by dopamine on smooth muscle contraction. This disinhibition facilitates the local release of Acetylcholine, an excitatory neurotransmitter, thereby increasing the amplitude and coordination of smooth muscle contractions (peristalsis) and accelerating the physiological rate of gastric emptying.

Mechanistic Constraints

The drug's mechanism is intrinsically constrained in its scope: its motility effects are largely limited to the upper GI tract. Furthermore, the molecule exhibits a non-therapeutic off-target interaction with hERG potassium ion channels in cardiac tissue, a secondary binding mechanism that imposes a physiological constraint on the process of cardiac repolarization.

Dosage and Administration Information

How to Use Tridom: Administration Guidelines

Tridom (Domperidone) is an acute-use medication governed by specific administration principles to ensure standardized use. These instructions specify the route, dosing limits, frequency, and duration.


Administration Scope

Instruction Detail
Route of administration Primarily Oral (tablet, suspension, orodispersible tablet); also available for Rectal use (suppository).
Dosing schedule The Single Oral Dose must not exceed 10 mg. The Maximum Total Daily Oral Dose is strictly 30 mg. Rectal dosing is 30 mg suppository, twice daily.
Timing in relation to meals Oral formulations must be taken before meals, ideally 15 to 30 minutes prior, as absorption is delayed by food.
Frequency and duration The medicine is taken up to three times per day, with doses spaced at least 4–6 hours apart. Treatment duration should not usually exceed seven days (1 week).

Standard Procedural Conditions

Administration is subject to specific constraints. For adolescents, use of tablets and suppositories is restricted to those 12 years of age or older and weighing 35 kg or more. The correct dosing frequency is reduced in patients with severe renal impairment due to altered elimination kinetics. When using the oral formulation, other agents such as antacids or acid suppressants should not be taken simultaneously; Domperidone is taken before meals, and these other agents after meals to prevent interference with drug absorption. If a dose is missed, it is omitted, and the regular schedule resumed without doubling the next dose.

Recent Clinical Evidence

Tridom: Recent Clinical Evidence

Clinical research on Tridom (domperidone) has primarily focused on its use in managing nausea, vomiting, and certain gastrointestinal motility disorders like chronic dyspepsia (indigestion) and gastroparesis.

Evaluation of the Compound

Research investigated the compound's target pathway through inhibition of dopamine (D2) receptors, which is believed to regulate the upper gastrointestinal tract's movement. Studies have also examined the potential for rapid changes and maintenance of symptom level with this medication in the target population.

Clinical trials collected tolerability data on the compound, primarily in adult populations. The research documented side effects that often included mild headache, drowsiness, dry mouth, and temporary nausea.

Comparative and Safety Findings

Studies have compared Tridom to older methods in trials to assess differences in outcomes for gastrointestinal conditions. Findings from these comparisons were mixed regarding differences in outcomes across all subgroups, indicating that treatment response may vary by individual. Research has also explored whether the compound, when used alongside a standard therapy, has a relationship with patient-reported quality of life measures.

Limitations and Risks

Studies have examined the consistency of documented events between short-term and longer-term periods. However, documentation of long-term effects beyond a specific duration (e.g., 24 months) is limited. Some studies assessed whether the compound was associated with changes in measured pain endpoints in certain patient groups.

There is an association between the use of Tridom and an increased risk of heart rhythm disorders (arrhythmia) and cardiac arrest, particularly in individuals over 60 years old or those taking doses higher than 30, mg daily. Limited data are available on use in pediatric or geriatric populations, and extrapolation of adult findings to these groups is not yet clear. The collected evidence provides data on the compound's use within the scope of these trials.

Frequently Asked Questions (FAQ)

Common questions about Tridom (FAQ)


Q: Does Tridom make you sleepy?

Official product information indicates that feeling tired or experiencing drowsiness is a possible side effect of the medicine. Regulatory advisories suggest that this effect may be intensified if the medicine is taken concurrently with alcohol.


Q: Is Tridom supposed to be taken every day?

According to official regulatory documents, the medicine is generally intended for acute use only. The treatment duration is typically described as not usually exceeding one week in duration. The official labeling specifies that the drug should be used at the lowest effective dose for the shortest period necessary.


Q: Is it normal to feel dizzy after taking Tridom?

Official sources note that dizziness can be described as a possible side effect in some patients. However, the regulatory documentation highlights that severe dizziness or fainting can be a symptom of a serious, documented heart rhythm disorder. Official documentation indicates that severe dizziness or fainting should be promptly reported to a healthcare professional.


Q: Do you need a prescription for Tridom?

In most major regions, including the UK, Canada, and Australia, the medicine is currently classified as a Prescription Only Medicine (POM). This means the medicine must be dispensed under the authority of a valid prescription from a doctor.


Q: What does 'contraindicated' mean for Tridom?

The term contraindicated in official drug labeling describes a specific health condition or situation where using the medicine is described as not permissible. This is because official documents indicate the risk of serious harm is documented to be greater than any potential benefit in that circumstance.


Q: Can I take Tridom if I have high blood pressure?

High blood pressure (hypertension) itself is not typically listed as a sole contraindication. However, the medicine is officially contraindicated if you have underlying cardiac diseases such as congestive heart failure or a known prolonged QT interval.


Q: How is Tridom different from other medicines that treat the same condition?

Tridom’s active ingredient, Domperidone, is known for its design to have minimal penetration of the blood-brain barrier. This characteristic helps focus its therapeutic effects on the digestive system and the Chemoreceptor Trigger Zone (CTZ), distinguishing its action profile from some antiemetic compounds.


Q: Does Tridom interact with alcohol?

Official patient information generally states that avoidance of alcohol is recommended while the medicine is being used. This is because alcohol consumption may increase the risk of side effects, such as feeling sleepy or dizzy, and could potentially worsen the documented risk of an irregular heartbeat.


Q: Is Tridom a controlled substance?

Regulatory agencies in the United States and other major global jurisdictions have not classified the medicine as a controlled substance.


Q: Does Tridom interact with herbal supplements?

Some official patient safety information notes that the medicine interacts with certain herbal supplements and notes that caution is advised. Specific interacting supplements are not consistently listed on official government documents, and the full patient information leaflet may provide additional detail.


Q: What is the risk of stopping Tridom suddenly?

Regulatory reports from various countries have noted a potential risk of psychiatric events, including anxiety and insomnia, following the sudden discontinuation or tapering of the medicine. This risk has been primarily observed in patients who used high doses for long periods in unapproved contexts.


Q: Are there any warnings about driving while taking Tridom?

Official product labeling contains a statement of caution regarding driving or operating machinery until a patient is aware of how the medicine affects them. This warning is due to the potential for side effects such as feeling dizzy or tired.


Q: Do older adults require a different starting dose of Tridom?

Official documents do not explicitly mandate a different starting dose for older adults. However, the regulatory information specifies the importance of using the medicine at the lowest effective dose for the shortest possible time, particularly in older patients, due to a documented increased cardiac risk.


Q: Can Tridom be purchased over-the-counter in any country?

While the medicine was historically available over-the-counter in many parts of the world, numerous regulatory bodies have since reclassified it as a Prescription Only Medicine. This change was made to manage documented safety concerns, ensuring use is supervised by a physician.


Q: Does Tridom cause problems with sleeping?

Official product information notes drowsiness as a possible side effect. Furthermore, regulatory reports have specifically noted insomnia as a possible psychiatric event that can follow the sudden cessation of long-term, high-dose use.


Q: What information is publicly available about Tridom's research?

Publicly available information regarding the medicine's research includes clinical study summaries, safety evaluations, and regulatory advisories. This information is published on official government health websites, such as those maintained by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA).


Q: Does Tridom have a black box warning?

While the specific term "black box warning" is unique to the U.S. regulatory system, the medicine carries a prominent advisory warning in various countries. This safety communication addresses the documented risk of serious cardiac side effects.

How should Tridom be stored and disposed of?

How to Store and Dispose of Tridom (Domperidone)

Official regulations require Tridom to be stored below 25°C (77°F) and protected from both light and moisture. The medication must be kept in its original container and must not be frozen. The official labeling mandates that the medicine be kept out of the sight and reach of children at all times.


For the oral suspension formulation, the product must be used within 3 months after opening the bottle, after which any remaining portion must be discarded. Disposal of unused or expired Tridom must not be done via wastewater (sinks or toilets). The required method is to use a local pharmaceutical take-back program or return the product to a pharmacy, following specific local waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tridom found in:

A-Z Index: